| GO ID | Ontology | GO Term | Term Definition |
Proteins |
GO:0016023 | CC | cytoplasmic, membrane-bounded vesicle | A membrane-bounded vesicle found in the cytoplasm of the cell. |
MYO1C, HAX1, KCNK1, WASL, AXIN1, SOCS1, AP2A2, NGF, TFRC, TF, ANG, CLTA, PDGFRB, FGFR1, C5AR1, FGFR2, BDNF, PRDX6, OPRL1, PLA2G4A, ARHGDIB, AGFG1, IST1, CXCR4, DST, KCNA1, HYAL2, MALL, HERC3, EBP, PKN1, CCDC88A, TMEM35, FNBP1L, WLS, CHIC1, TMEM198, SLC39A4, ARHGAP30, SLC30A8, ARL14, COMMD1, ARRDC4, RIN3, PIFO, PHLDA1, SNX33, USP6NL, HPS1, ARHGEF2, PIGT, SGK3, OPTN, STARD4, NRBF2, IFT74, SNX18, FNBP1, NEU1, SIGMAR1, MAPKAP1, ZFYVE21, ANP32E, DUSP16, CD93, RAB6B, SYBU, TAOK2, MYO6, SNX6, SNX9, ARFGEF2 |
GO:0016024 | BP | CDP-diacylglycerol biosynthetic process | The chemical reactions and pathways resulting in the formation of CDP-diacylglycerol, CDP-1,2-diacylglycerol, a substance composed of diacylglycerol in glycosidic linkage with cytidine diphosphate. |
CDS2, GPAT3, LCLAT1, GPAT4, CDS1, GPAM, AGPAT4, AGPAT3 |
GO:0016028 | CC | rhabdomere | The specialized microvilli-containing organelle on the apical surfaces of a photoreceptor cell containing the visual pigment rhodopsin and most of the proteins involved in phototransduction. |
MERTK |
GO:0016031 | BP | tRNA import into mitochondrion | The directed movement of tRNA, transfer ribonucleic acid, from the cytoplasm into a mitochondrion. |
TOMM20 |
GO:0016032 | BP | viral process | A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle. |
IPO5, BIN1, ACOT8, XPO1, NUPL2, CFLAR, EIF4G3, BUB1, SGTA, SYNCRIP, CCNT1, BRD4, NUP155, AP1G2, SNAPIN, HLA-B, HLA-DRA, APOA2, AMBP, MMP1, TP53, SLC25A5, KRT18, KRT8, FYN, RB1, EIF4E, NPM1, LYN, VIM, KRT19, KRT7, HNRNPA1, POLA1, HSPD1, RALA, TOP1, SLC25A4, TPR, UNG, FDPS, CD1D, H2AFX, CREB1, PDGFRA, ATF7, PSMC3, ERCC2, RCC1, VCAM1, POLR2E, CCNA2, PSMB1, FBLN1, SP100, PSMA3, PSMA4, MAPK3, PIK3R1, PSMB8, PSMB9, PSMB4, PSMB5, MAPK1, RBL1, CDC25C, HLA-A, YWHAB, FCGR2B, PSMC2, TRIM23, LTBR, NUP62, IL6ST, PSMB10, STAT3, TSPAN7, SYK, RANBP1, CBX5, CENPA, PSMB3, NUP153, RANBP2, TSC2, MRE11A, GTF2A2, MSH6, RAD23A, NUP107, EIF4A1, ABCE1, RHOA, YWHAE, RBX1, GRB2, DYNLL1, RACK1, UBE2I, RAE1, GTF2B, MDM2, SET, SATB1, C1QBP, BAX, MFGE8, EP300, NUP160, DLG1, CALCOCO2, PAK2, DYNC1I2, HDAC1, CUL2, CUL4A, CDK13, SEPT6, MORC3, EIF4A2, CUL7, KARS, ZMYND11, TCEB1, TAF5, ZYX, MICB, UBR4, CRTC3, ATF7IP, CENPU, SUPT6H, COPS6, WAPL, CARM1, ABI1, NUP93, PDZD8, NUP43, NUP37, NUP35, GADD45GIP1, WDR48, NUP210, GBF1, NUP205, CREBBP, KAT2B, RAD50, CUL5, SEH1L, BICD1, PRMT6, SRPK1, RBM15, SPEN, NUP88, MAP3K5, PAAF1, NDC1, HTATIP2, NUP58, NUP85, ULBP3, PDCL3, SP110, PARD6A, CD93, LMBRD1, RNF216, UCKL1, ABI2, NXF1, ZC3H7B, ATP6V1H, FBXL2, PILRA, NUP50, BTRC, TLN1, HCFC2, WASF2 |
GO:0016034 | MF | maleylacetoacetate isomerase activity | Catalysis of the reaction: 4-maleylacetoacetate = 4-fumarylacetoacetate. |
GSTZ1 |
GO:0016035 | CC | zeta DNA polymerase complex | A heterodimeric DNA polymerase complex that catalyzes error-prone DNA synthesis in contexts such as translesion synthesis and double-stranded break repair. First characterized in Saccharomyces, in which the subunits are Rev3p and Rev7p; a third protein, Rev1p, is often associated with the polymerase dimer. |
REV3L |
GO:0016036 | BP | cellular response to phosphate starvation | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of phosphate. |
COMT |
GO:0016042 | BP | lipid catabolic process | The chemical reactions and pathways resulting in the breakdown of lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. |
PLIN1, PLA2G2A, PRDX6, ADORA1, LIPA, PLA2G5, PPT1, PLCD1, PLA2G16, PAFAH1B2, LIPE, PLCXD2, PLA2G7, PLD1, PAFAH1B3, IAH1, PLA1A, PLCXD3, DAGLB, ABHD4, LIPH, TBL1XR1, PLA2G12A, PLCB1 |
GO:0016045 | BP | detection of bacterium | The series of events in which a stimulus from a bacterium is received and converted into a molecular signal. |
CD1D, PGLYRP2 |
GO:0016046 | BP | detection of fungus | The series of events in which a stimulus from a fungus is received and converted into a molecular signal. |
TLR4 |
GO:0016049 | BP | cell growth | The process in which a cell irreversibly increases in size over time by accretion and biosynthetic production of matter similar to that already present. |
ATP6V0E1, NUPR1, SOCS5, TGFB1, TYMS, ITGB3, IL6, EDN1, ITGAV, SLC3A2, AR, BCL2, IL7R, DDX5, ADRA1A, EMP1, EMP3, MTPN, SEC61A1, TGFB2, TGFBR3, NOTCH2, LAMTOR1, BRAT1, SGMS1, NDNF, PRMT6, RRAGC, ATAD3A, PAK7, NDRG4, LAMTOR2 |
GO:0016050 | BP | vesicle organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a vesicle. |
WASL, SNX4, EPS15, CAV2, CAV1, SNX1, FNBP1L, ZFYVE16, SNX33, ALS2, SNX18, PINK1, FBXO5, SNX12, SNX6, SNX9, SNX5 |
GO:0016051 | BP | carbohydrate biosynthetic process | The chemical reactions and pathways resulting in the formation of carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y. |
ST8SIA6, CHST11 |
GO:0016052 | BP | carbohydrate catabolic process | The chemical reactions and pathways resulting in the breakdown of carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y. |
DERA |
GO:0016055 | BP | Wnt signaling pathway | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state. |
KIAA0922, DDX3X, TAX1BP3, AXIN1, TGFB1I1, HBP1, SNX3, CTNND1, LRP5, VPS26A, LRP6, TNKS, WISP1, WNT2, UBC, DRD2, CPE, PLCG2, APC, CD24, GRK5, CTNNB1, DDIT3, WNT5A, GRK6, CSNK1A1, CSNK1D, CSNK1E, GSK3B, PRKAA2, WNT3, RBX1, RPS27A, UBA52, SKP1, DAB2, XIAP, NDP, HHEX, TLE1, TLE3, AES, CUL3, KLHL12, WLS, TMEM198, CPZ, SOSTDC1, USP34, NPHP3, ZBTB33, TRABD2A, AMOTL1, APCDD1, CCAR2, RTF1, WNT2B, DACT3, ZBED3, KREMEN1, VPS35, PITX2, SOST, RSPO3, WNT5B, TNKS2, LGR6, CSNK1G1, BRD7, CYLD, RNF146, DACT1, MARK1, DKK3, VPS29, DKK2, ZRANB1, HMGXB4, TNIK, FZD4, NDRG2, MACF1, INVS, BTRC, WIF1, LRRFIP2, SPIN1, WNT6, CSNK1G3 |
GO:0016056 | BP | rhodopsin mediated signaling pathway | The series of molecular signals generated as a consequence of excitation of rhodopsin by a photon and the events that convert the absorbed photons into a cellular response. |
CNGA1, GNB1 |
GO:0016062 | BP | adaptation of rhodopsin mediated signaling | The process in which a rhodopsin-mediated signaling pathway is adjusted to modulate the sensitivity and response of a visual system to light stimuli (that might vary over more than 6 magnitudes in intensity) without response saturation. |
RDH11 |
GO:0016064 | BP | immunoglobulin mediated immune response | An immune response mediated by immunoglobulins, whether cell-bound or in solution. |
BCL10, CD74, IL4R, CD27, PRKCD, INPP5D |
GO:0016070 | BP | RNA metabolic process | The cellular chemical reactions and pathways involving RNA, ribonucleic acid, one of the two main type of nucleic acid, consisting of a long, unbranched macromolecule formed from ribonucleotides joined in 3',5'-phosphodiester linkage. |
RBFOX2, DUSP11, TSN, DDX54, DDX24 |
GO:0016071 | BP | mRNA metabolic process | The chemical reactions and pathways involving mRNA, messenger RNA, which is responsible for carrying the coded genetic 'message', transcribed from DNA, to sites of protein assembly at the ribosomes. |
CEBPG, PABPC3 |
GO:0016072 | BP | rRNA metabolic process | The chemical reactions and pathways involving rRNA, ribosomal RNA, a structural constituent of ribosomes. |
NIFK |
GO:0016075 | BP | rRNA catabolic process | The chemical reactions and pathways resulting in the breakdown of rRNA, ribosomal RNA, a structural constituent of ribosomes. |
EXOSC6, XRN1, EXOSC4, DIS3 |
GO:0016077 | BP | snoRNA catabolic process | The chemical reactions and pathways resulting in the breakdown of snoRNA, small nucleolar RNA, any of a class of small RNAs that are associated with the eukaryotic nucleus as components of small nucleolar ribonucleoproteins. |
NUDT16 |
GO:0016079 | BP | synaptic vesicle exocytosis | Fusion of intracellular membrane-bounded vesicles with the pre-synaptic membrane of the neuronal cell resulting in release of neurotransmitter into the synaptic cleft. |
PIP5K1C, SNAPIN, SNAP25, VAMP2, CDK5, CPLX2, TRIM9, PCLO |
GO:0016080 | BP | synaptic vesicle targeting | The process in which synaptic vesicles are directed to specific destination membranes, mediated by molecules at the vesicle membrane and target membrane surfaces. |
PSEN1, NLGN1 |
GO:0016081 | BP | synaptic vesicle docking | The initial (indirect) attachment of a synaptic vesicle membrane to the presynaptic active zone membrane, mediated by proteins protruding from the membrane and proteins of the presynaptic active zone cytoplasmic component. |
SNAP25, STX3, BLOC1S6 |
GO:0016082 | BP | synaptic vesicle priming | A process that converts synaptic vesicles to a state of competence for calcium triggered fusion with the active zone membrane by bringing the two membranes into very close proximity. Priming typically (but not always) occurs after docking (Jahn and Fasshauer, 2012). Primed vesicles are also capable of spontaneously fusing with the active zone membrane. |
SNAP23, SYNJ1, SNAP29, SNAP25 |
GO:0016098 | BP | monoterpenoid metabolic process | The chemical reactions and pathways involving monoterpenoid compounds, terpenoids having a C10 skeleton. |
CYP2E1, CYP3A4, CYP2D6, CYP2C9 |
GO:0016101 | BP | diterpenoid metabolic process | The chemical reactions and pathways involving diterpenoid compounds, terpenoids with four isoprene units. |
EGFR, SRD5A1, STAR, PDE3A |
GO:0016125 | BP | sterol metabolic process | The chemical reactions and pathways involving sterols, steroids with one or more hydroxyl groups and a hydrocarbon side-chain in the molecule. |
CYP17A1, CYP11A1, CYP21A2, FDX1, CYP19A1, CYP11B1, CYP11B2, CYP1B1, CYP51A1, FDX1L, CYP4V2, EBPL, CYP8B1 |
GO:0016126 | BP | sterol biosynthetic process | The chemical reactions and pathways resulting in the formation of sterols, steroids with one or more hydroxyl groups and a hydrocarbon side-chain in the molecule. |
TM7SF2, CH25H, SQLE, MSMO1 |
GO:0016137 | BP | glycoside metabolic process | The chemical reactions and pathways involving glycosides, compounds in which a glycosyl group is substituted into a hydroxyl, thiol or selenol group in another compound. |
TH |
GO:0016139 | BP | glycoside catabolic process | The chemical reactions and pathways resulting in the breakdown of glycosides, compounds in which a glycosyl group is substituted into a hydroxyl, thiol or selenol group in another compound. |
FUCA1, FUCA2, GBA2 |
GO:0016150 | MF | translation release factor activity, codon nonspecific | A translation release factor that is not specific to particular codons; binds to guanine nucleotides. |
ICT1, C12orf65 |
GO:0016151 | MF | nickel cation binding | Interacting selectively and non-covalently with nickel (Ni) cations. |
CA3 |
GO:0016154 | MF | pyrimidine-nucleoside phosphorylase activity | Catalysis of the reaction: pyrimidine nucleoside + phosphate = pyrimidine + alpha-D-ribose 1-phosphate. |
TYMP |
GO:0016155 | MF | formyltetrahydrofolate dehydrogenase activity | Catalysis of the reaction: 10-formyltetrahydrofolate + H(2)O + NADP(+) = (6S)-5,6,7,8-tetrahydrofolate + CO(2) + H(+) + NADPH. |
ALDH1L1, ALDH1L2 |
GO:0016160 | MF | amylase activity | Catalysis of the hydrolysis of amylose or an amylose derivative. |
MGAM |
GO:0016174 | MF | NAD(P)H oxidase activity | Catalysis of the reaction: NAD(P)H + H+ + O2 = NAD(P)+ + hydrogen peroxide. |
KMO, AIFM1, NOX4, DUOX2, DUOX1 |
GO:0016175 | MF | superoxide-generating NADPH oxidase activity | Catalysis of the reaction: NAD(P)H + O2 = NAD(P)H + O2-. |
CYBB, NCF2, NOX5, NOX4 |
GO:0016176 | MF | superoxide-generating NADPH oxidase activator activity | Increases the activity of the enzyme superoxide-generating NADPH oxidase. |
SH3PXD2B, PDGFB, NCF4, NOXA1 |
GO:0016180 | BP | snRNA processing | Any process involved in the conversion of a primary small nuclear RNA (snRNA) transcript into a mature snRNA molecule. |
CPSF3L, INTS3, INTS1, INTS4, INTS7, INTS10, INTS6 |
GO:0016188 | BP | synaptic vesicle maturation | Steps required to form an initiated synaptic vesicle into a fully formed and transmissible synaptic vesicle. |
SNAPIN, STXBP1, DLG4, PICALM |
GO:0016189 | BP | synaptic vesicle to endosome fusion | Fusion of a synaptic vesicle with an endosome. |
EEA1 |
GO:0016191 | BP | synaptic vesicle uncoating | The removal of the protein coat on a synaptic vesicle following the pinching step at the end of budding from the presynaptic membrane. |
SYNJ1 |
GO:0016192 | BP | vesicle-mediated transport | A cellular transport process in which transported substances are moved in membrane-bounded vesicles; transported substances are enclosed in the vesicle lumen or located in the vesicle membrane. The process begins with a step that directs a substance to the forming vesicle, and includes vesicle budding and coating. Vesicles are then targeted to, and fuse with, an acceptor membrane. |
TBC1D4, RAB11FIP3, AP1G2, ZFPL1, KIF20A, SFT2D2, LRPAP1, PRKCI, NSF, TSC2, GDI2, VAMP7, AP1S2, NCALD, RAB11A, RAB1A, VAMP2, AP1B1, GOLGA4, PICALM, RABEP1, SEC23A, TRIP10, VAMP3, ARL17A, AHI1, BVES, RAB2B, SFT2D1, ARAP3, YIPF5, RAB39B, FNBP1, OSBPL1A, SPTBN4, BLZF1, SYTL2, ARFGAP3, FMN2, ADAMTS9, VTI1B, GGA2, GGA1, MYO5B, MAPK8IP3, MAPK8IP1, ERGIC3, GOLT1B, MYO5A |
GO:0016197 | BP | endosomal transport | The directed movement of substances into, out of, or mediated by an endosome, a membrane-bounded organelle that carries materials newly ingested by endocytosis. It passes many of the materials to lysosomes for degradation. |
VPS37C, WASH1, DCLK1, AP5Z1, CHMP2A, VPS4B, STAM2, RASSF9, ABCA1, UBC, NSG1, RPS27A, UBA52, BLOC1S1, PICALM, SQSTM1, ZFYVE16, VPS37A, SNX33, STAM, ALS2, SNX18, TINAGL1, AP5M1, CHMP4B, VTA1, SNX9 |
GO:0016198 | BP | axon choice point recognition | The recognition of molecules at a choice point by an axon growth cone; at a choice point the growth cone determines the direction of its future growth. |
GAP43 |
GO:0016199 | BP | axon midline choice point recognition | The recognition of molecules at the central nervous system midline choice point by an axon growth cone; this choice point determines whether the growth cone will cross the midline. |
APP, ROBO3, ROBO2 |
GO:0016202 | BP | regulation of striated muscle tissue development | Any process that modulates the frequency, rate or extent of striated muscle development. |
TGFB1, CENPF, MTPN, SMAD3 |
GO:0016203 | BP | muscle attachment | The developmental process in which a skeletal muscle attaches to its target (such as bone or body wall). |
DMD |
GO:0016206 | MF | catechol O-methyltransferase activity | Catalysis of the reaction: S-adenosyl-L-methionine + a catechol = S-adenosyl-L-homocysteine + a guaiacol. |
COMT |
GO:0016208 | MF | AMP binding | Interacting selectively and non-covalently with AMP, adenosine monophosphate. |
CYB5R3, APRT, FBP1, PRKAG1, PRPS1, ACSS2, ACSS1 |
GO:0016209 | MF | antioxidant activity | Inhibition of the reactions brought about by dioxygen (O2) or peroxides. Usually the antioxidant is effective because it can itself be more easily oxidized than the substance protected. The term is often applied to components that can trap free radicals, thereby breaking the chain reaction that normally leads to extensive biological damage. |
HP, APOE, ALB, S100A9, MT3, PRDX2, AAED1, TP53INP1, VIMP, FAM213A |
GO:0016212 | MF | kynurenine-oxoglutarate transaminase activity | Catalysis of the reaction: L-kynurenine + 2-oxoglutarate = 4-(2-aminophenyl)-2,4-dioxobutanoate + L-glutamate. |
GOT2 |
GO:0016213 | MF | linoleoyl-CoA desaturase activity | Catalysis of the reaction: linoleoyl-CoA + reduced acceptor + O2 = gamma-linolenoyl-CoA + acceptor + 2 H2O. |
FADS2 |
GO:0016222 | CC | procollagen-proline 4-dioxygenase complex | A protein complex that catalyzes the formation of procollagen trans-4-hydroxy-L-proline and succinate from procollagen L-proline and 2-oxoglutarate, requiring Fe2+ and ascorbate. Contains two alpha subunits that contribute to most parts of the catalytic sites, and two beta subunits that are identical to protein-disulfide isomerase. |
P4HB, P4HA1 |
GO:0016226 | BP | iron-sulfur cluster assembly | The incorporation of iron and exogenous sulfur into a metallo-sulfur cluster. |
CIAO1, IBA57, ISCA1, FAM96A, NFU1, FAM96B |
GO:0016229 | MF | steroid dehydrogenase activity | Catalysis of an oxidation-reduction (redox) reaction in which one substrate is a sterol derivative. |
HSD17B11 |
GO:0016230 | MF | sphingomyelin phosphodiesterase activator activity | Increases the activity of the enzyme sphingomyelin phosphodiesterase. |
STX4, NSMAF |
GO:0016231 | MF | beta-N-acetylglucosaminidase activity | Catalysis of the hydrolysis of terminal non-reducing N-acetyl-D-glucosamine residues in N-acetyl-beta-D-glucosaminides. |
MGEA5 |
GO:0016233 | BP | telomere capping | A process in which telomeres are protected from degradation and fusion, thereby ensuring chromosome stability by protecting the ends from both degradation and from being recognized as damaged DNA. May be mediated by specific single- or double-stranded telomeric DNA binding proteins. |
TERF1, HIST1H4A, PRKDC, ACD, OBFC1, POT1 |
GO:0016234 | CC | inclusion body | A discrete intracellular part formed of aggregated molecules such as proteins or other biopolymers. |
HSP90AB1, HSPA1A, HSPA1B, GYS1, MT3, SNCA, PSMC4, SQSTM1, HDAC6, MIOX, BAG5 |
GO:0016235 | CC | aggresome | An inclusion body formed by dynein-dependent retrograde transport of an aggregated protein on microtubules. |
UBD, PARK2, TRIM37, EEF2, POLD1, EPS15, PSEN1, SQSTM1, RAB11B, DBF4B, SYNE2, MVB12A, SEC62, HDAC6, GIT1, ORC6, EID1, CABIN1 |
GO:0016236 | BP | macroautophagy | The major inducible pathway for the general turnover of cytoplasmic constituents in eukaryotic cells, it is also responsible for the degradation of active cytoplasmic enzymes and organelles during nutrient starvation. Macroautophagy involves the formation of double-membrane-bounded autophagosomes which enclose the cytoplasmic constituent targeted for degradation in a membrane-bounded structure. Autophagosomes then fuse with a lysosome (or vacuole) releasing single-membrane-bounded autophagic bodies that are then degraded within the lysosome (or vacuole). Though once thought to be a purely non-selective process, it appears that some types of macroautophagy, e.g. macropexophagy, macromitophagy, may involve selective targeting of the targets to be degraded. |
PARK2, ATG13, ULK1, ATG12, MFN2, TOMM40, UBC, PRKAG1, PRKAA2, GABARAPL2, RPS27A, UBA52, DYNLL1, CLN3, TCIRG1, SQSTM1, NBR1, RHEB, TOMM20, WIPI1, LAMTOR1, TOMM5, PIK3C3, RB1CC1, OPTN, PIK3R4, MLST8, PINK1, MAP1LC3B, GABARAPL1, ATG10, MAP1LC3A, RRAGC, ZFYVE1, RRAGD, TOMM22, TOMM7, HDAC6, PRKAG3, LAMTOR3, LAMTOR2, WIPI2 |
GO:0016239 | BP | positive regulation of macroautophagy | Any process, such as recognition of nutrient depletion, that activates or increases the rate of macroautophagy to bring cytosolic macromolecules to the vacuole/lysosome for degradation. |
SUPT5H, BNIP3L, TRIM13, ULK1, EPM2A, DCN, HMOX1, PRKAA2, SESN2, PAFAH1B2, BNIP3, SQSTM1, HIF1A, RAB12, LARP1, WAC, PINK1, SCOC |
GO:0016241 | BP | regulation of macroautophagy | Any process that modulates the frequency, rate or extent of macroautophagy. |
ATP6V0E1, ATP6V1G1, VPS26A, ERN1, ATP6V1G2, GAPDH, UCHL1, ATP6V1B2, ATP6V1C1, MAPK8, PRKAA2, ATP6V0D1, CDK5, ATP6V1C2, ATP6V0A1, EXOC4, VPS35, ATP13A2, EXOC1, ATP6V1H, SNX6, EXOC7, SH3GLB1, ATP6V1D, SNX5 |
GO:0016242 | BP | negative regulation of macroautophagy | Any process that stops, prevents, or reduces the frequency, rate or extent of macroautophagy. |
NPC1, CLN3, PINK1, NRBP2, LZTS1, POLDIP2 |
GO:0016243 | BP | regulation of autophagosome size | Any process that modulates the size of the autophagosome. |
ATP13A2 |
GO:0016247 | MF | channel regulator activity | Modulates the activity of a channel. A channel catalyzes energy-independent facilitated diffusion, mediated by passage of a solute through a transmembrane aqueous pore or channel. |
CACNG8 |
GO:0016248 | MF | channel inhibitor activity | Stops, prevents, or reduces the activity of a channel. A channel catalyzes energy-independent facilitated diffusion, mediated by passage of a solute through a transmembrane aqueous pore or channel. |
BCL2 |
GO:0016250 | MF | N-sulfoglucosamine sulfohydrolase activity | Catalysis of the reaction: N-sulfo-D-glucosamine + H2O = D-glucosamine + sulfate. |
SGSH |
GO:0016254 | BP | preassembly of GPI anchor in ER membrane | The stepwise addition of the components of the GPI anchor on to phosphatidylinositol lipids in the endoplasmic reticulum membrane. |
PIGA, PIGF, PIGH, PIGG, PIGW, PIGX, PIGC |
GO:0016255 | BP | attachment of GPI anchor to protein | A transamidation reaction that results in the cleavage of the polypeptide chain and the concomitant transfer of the GPI anchor to the newly formed carboxy-terminal amino acid of the anchored protein. The cleaved C-terminal contains the C-terminal GPI signal sequence of the newly synthesized polypeptide chain. |
PLAUR, PGAP1, PIGK, PIGT, PIGU |
GO:0016256 | BP | N-glycan processing to lysosome | The modification of high-mannose N-glycans by UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase and the subsequent removal of the N-acetylglucosamine residues yielding mannose-6-P that occurs in the ER-Golgi apparatus to N-glycans destined for the lysosome. |
GNPTAB, GNPTG |
GO:0016259 | BP | selenocysteine metabolic process | The chemical reactions and pathways involving selenocysteine, an essential component of glutathione peroxidase and some other proteins. |
SARS, SEPSECS |
GO:0016262 | MF | protein N-acetylglucosaminyltransferase activity | Catalysis of the reaction: UDP-N-acetyl-D-glucosamine + protein = UDP + 4-N-(N-acetyl-D-glucosaminyl)-protein. |
OGT |
GO:0016264 | BP | gap junction assembly | Assembly of gap junctions, which are found in most animal tissues, and serve as direct connections between the cytoplasms of adjacent cells. They provide open channels through the plasma membrane, allowing ions and small molecules (less than approximately a thousand daltons) to diffuse freely between neighboring cells, but preventing the passage of proteins and nucleic acids. |
GJA1, CTNNA1, GJA5, GJC1, PKP2 |
GO:0016266 | BP | O-glycan processing | The stepwise addition of carbohydrate or carbohydrate derivative residues to the initially added O-linked residue (usually GalNAc) to form a core O-glycan structure. |
B4GALT5, ST6GAL1, MUC1, MUC5AC, MUC3A, GALNT2, GALNT1, ST3GAL1, ST3GAL3, ST3GAL4, ST3GAL2, MUC21, GALNT5, GALNT7, GALNT10, MUC20, MUC15, GALNT15, GALNT4, XXYLT1, CHST4, B3GNT7, MUCL1, GALNT14, MUC4, B3GNT5, MUC13, ST6GALNAC4, B3GNT2, ST6GALNAC2 |
GO:0016272 | CC | prefoldin complex | A multisubunit chaperone that is capable of delivering unfolded proteins to cytosolic chaperonin, which it acts as a cofactor for. In humans, the complex is a heterohexamer of two PFD-alpha and four PFD-beta type subunits. In Saccharomyces cerevisiae, it also acts in the nucleus to regulate the rate of elongation by RNA polymerase II via a direct effect on histone dynamics. |
PFDN6, PFDN5, PFDN4 |
GO:0016274 | MF | protein-arginine N-methyltransferase activity | Catalysis of the reaction: S-adenosyl-L-methionine + (protein)-arginine = S-adenosyl-L-homocysteine + (protein)-N-methyl-arginine. |
PRMT3, CARM1, PRMT6, PRMT1 |
GO:0016278 | MF | lysine N-methyltransferase activity | Catalysis of the transfer of a methyl group from S-adenosyl-L-methionine to the epsilon-amino group of a lysine residue. |
SETD9, KMT5A |
GO:0016279 | MF | protein-lysine N-methyltransferase activity | Catalysis of the transfer of a methyl group from S-adenosyl-L-methionine to the epsilon-amino group of a lysine residue in a protein substrate. |
EZH2, METTL10, ETFBKMT, SETD6, SETD7, N6AMT2, METTL21A, EHMT2, KMT5A |
GO:0016281 | CC | eukaryotic translation initiation factor 4F complex | The eukaryotic translation initiation factor 4F complex is composed of eIF4E, eIF4A and eIF4G; it is involved in the recognition of the mRNA cap, ATP-dependent unwinding of the 5'-terminal secondary structure and recruitment of the mRNA to the ribosome. |
EIF4G3, EIF4E, EIF4B, EIF4A1, EIF4A2 |
GO:0016282 | CC | eukaryotic 43S preinitiation complex | A protein complex composed of the 40S ribosomal subunit plus eIF1A, eIF3, and eIF2-GTP-bound methionyl-initiator methionine tRNA. |
EIF3J, EIF3B, EIF3A, DHX29, EIF3K |
GO:0016287 | MF | glycerone-phosphate O-acyltransferase activity | Catalysis of the reaction: acyl-CoA + glycerone phosphate = 1-acylglycerone 3-phosphate + CoA. |
GNPAT |
GO:0016289 | MF | CoA hydrolase activity | Catalysis of the reaction: X-CoA + H2O = X + CoA; X may be any group. |
ACOT8, NUDT7 |
GO:0016290 | MF | palmitoyl-CoA hydrolase activity | Catalysis of the reaction: palmitoyl-CoA + H2O = CoA + palmitate. |
ACOT7, ACOT8, GNPAT, PPT1, THEM4, ACOT4 |
GO:0016295 | MF | myristoyl-[acyl-carrier-protein] hydrolase activity | Catalysis of the reaction: myristoyl-[acyl-carrier protein] + H2O = [acyl-carrier protein] + myristate. |
FASN |
GO:0016296 | MF | palmitoyl-[acyl-carrier-protein] hydrolase activity | Catalysis of the reaction: palmitoyl-[acyl-carrier protein] + H2O = [acyl-carrier protein] + palmitate. |
FASN |
GO:0016298 | MF | lipase activity | Catalysis of the hydrolysis of a lipid or phospholipid. |
LYPLA1, AADAC, LIPA |
GO:0016301 | MF | kinase activity | Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule. |
CDC7, PIK3CD, CHEK1, FAM20B, RAF1, CCL3, BCR, PRPS2, PKM, CDK2, MAPK3, MAPK1, WEE1, AKT1, CSK, PIK3CA, PIK3CB, MAPK8, CSNK1A1, PIK3CG, GSK3B, CDK7, IRAK1, PLK1, PRPS1, CDK5, DGKZ, PRKD1, RPS6KA2, RPS6KA1, PKN2, CERKL, SGMS1, PIK3C3, SGMS2, MASTL, NEK1, PKMYT1, PINK1, TPK1, TRRAP |
GO:0016303 | MF | 1-phosphatidylinositol-3-kinase activity | Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol + ATP = a 1-phosphatidyl-1D-myo-inositol 3-phosphate + ADP + 2 H(+). |
PIK3CD, PIK3C2A, FGF18, FGF19, FGF2, FGFR1, FGF7, FGFR2, PIK3R1, FGF9, IRS1, PIK3CA, PIK3CB, PIK3CG, GRB2, PTPN11, GAB1, PIK3C3, FRS2, PIK3R4, KL, IRS2 |
GO:0016308 | MF | 1-phosphatidylinositol-4-phosphate 5-kinase activity | Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4-phosphate + ATP = 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + ADP + 2 H(+). |
PIP5K1B, PIP5K1C, PIP4K2B, PIKFYVE |
GO:0016309 | MF | 1-phosphatidylinositol-5-phosphate 4-kinase activity | Catalysis of the reaction: ATP + 1-phosphatidyl-1D-myo-inositol 5-phosphate = ADP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate. |
PIP4K2B |
GO:0016310 | BP | phosphorylation | The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide. |
TK2, PIK3CD, PDXK, FAM20B, PAPSS2, PGK1, TK1, TOP1, PRPS2, CKB, CKMT1A, CKMT2, MAPK3, DCK, EPHB2, AKT1, GK, CHKA, STAT3, HTR2B, PIK3CA, PIK3CB, PIK3CG, SEPHS1, LIMK2, ALDH18A1, PRPS1, CDK5, MVK, TNK2, COASY, PAK2, ITPK1, CERKL, NADK2, DGKK, IDNK, PPIP5K1, GK5, SGMS1, DGKH, SGMS2, DCAKD, RFK, PINK1, PANK2, UCK2, TOLLIP, TPK1, PANK3, UCK1, ETNK1, NMRK1, UCKL1, LIMD1, SHPK, AK3, CHKB, TRRAP |
GO:0016311 | BP | dephosphorylation | The process of removing one or more phosphoric (ester or anhydride) residues from a molecule. |
FBP2, INPP4B, PFKFB2, ALPL, CA3, BPGM, PTPRC, FBP1, ACPP, PFKFB1, PGAM1, NT5E, PTPRB, PON1, DUSP3, PPP1CA, PPP3CA, DUSP8, ITPK1, LPIN1, DUSP5, PFKFB3, PFKFB4, PPIP5K1, NT5DC3, THNSL2, SGPP2, DUSP18, NT5C, PXYLP1, NUDT16, INPP4A, INPP5K, G6PC3, DUSP23, DUSP16, NT5DC2, ACP6, DUSP13, MINPP1, DUSP10 |
GO:0016312 | MF | inositol bisphosphate phosphatase activity | Catalysis of the reaction: myo-inositol bisphosphate + H2O = myo-inositol phosphate + phosphate. |
INPP5K |
GO:0016314 | MF | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity | Catalysis of the reaction: phosphatidylinositol-3,4,5-trisphosphate + H2O = phosphatidylinositol-4,5-bisphosphate + phosphate. |
PTEN, INPP5D |